{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:14:30Z","timestamp":1788621270279,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trim.2026.102438","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:23:01Z","timestamp":1787325781000},"page":"102438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Addition of low-dose antithymocyte globulin to post-transplant cyclophosphamide for effective graft-versus-host disease prophylaxis in peripheral blood stem cell transplantation"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-5763","authenticated-orcid":false,"given":"Dong Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5553","authenticated-orcid":false,"given":"Ja Min","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1786-0345","authenticated-orcid":false,"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-931X","authenticated-orcid":false,"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-397X","authenticated-orcid":false,"given":"Junshik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102438_bb0005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17474086.2023.2273847","article-title":"The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Maurer","year":"2023","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.trim.2026.102438_bb0010","first-page":"3192","article-title":"The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Ho","year":"2001","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.trim.2026.102438_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","article-title":"Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT","volume":"11","author":"Ruggeri","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trim.2026.102438_bb0025","unstructured":"Robinson, T. M., O'Donnell, P. V., Fuchs, E. J. & Luznik, L. in Semin. Hematol. 90\u201397 (Elsevier)."},{"key":"10.1016\/j.trim.2026.102438_bb0030","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/cncr.31228","article-title":"Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide","volume":"124","author":"Ruggeri","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.trim.2026.102438_bb0035","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1002\/cncr.29651","article-title":"Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation","volume":"121","author":"Rosenberg","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.trim.2026.102438_bb0040","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbmt.2018.07.008","article-title":"Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplants for hematological malignancies","volume":"24","author":"Law","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0045","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102438_bb0050","article-title":"Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trim.2026.102438_bb0055","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41375-024-02225-7","article-title":"ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?","volume":"38","author":"Penack","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2026.102438_bb0060","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.bbmt.2020.06.005","article-title":"Preconditioning absolute lymphocyte count and transplantation outcomes in matched related donor allogeneic hematopoietic stem cell transplantation recipients with reduced-intensity conditioning and antithymocyte globulin treatment","volume":"26","author":"Woo","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/ejh.14165","article-title":"Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies in Korea","volume":"112","author":"Kim","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.trim.2026.102438_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0080","first-page":"1","article-title":"Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide conditioning in patients with central nervous system lymphoma: a phase II study","author":"Kim","year":"2025","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.trim.2026.102438_bb0085","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/bjh.70303","article-title":"Donor age and type in allogeneic haematopoietic stem cell transplantation: strong effect in MDS, limited in AML","volume":"208","author":"Kim","year":"2026","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2026.102438_bb0090","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European conference on infections in leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.trim.2026.102438_bb0095","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2026.102438_bb0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/bmt.2015.305","article-title":"Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP\u2013EBMT analysis on patients with AML in remission","volume":"51","author":"Ruggeri","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5045\/br.2022.2022194","article-title":"Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis","volume":"57","author":"Kim","year":"2022","journal-title":"Blood Res."},{"key":"10.1016\/j.trim.2026.102438_bb0110","article-title":"Post-transplant cyclophosphamide in matched donor transplantation: are we there yet?","volume":"73","author":"Lazzari","year":"2025","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.trim.2026.102438_bb0115","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2026.102438_bb0120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4049\/jimmunol.145.5.1303","article-title":"Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion","volume":"145","author":"Eto","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2026.102438_bb0125","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bbmt.2015.01.020","article-title":"Single-agent high-dose cyclophosphamide for graft-versus-host disease prophylaxis in human leukocyte antigen\u2013matched reduced-intensity peripheral blood stem cell transplantation results in an unacceptably high rate of severe acute graft-versus-host disease","volume":"21","author":"Bradstock","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s44313-024-00049-z","article-title":"Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation","volume":"60","author":"Koh","year":"2025","journal-title":"Blood Res."},{"key":"10.1016\/j.trim.2026.102438_bb0135","doi-asserted-by":"crossref","first-page":"587. e581","DOI":"10.1016\/j.jtct.2022.06.006","volume":"28","author":"Battipaglia","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.trim.2026.102438_bb0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41409-023-01956-y","article-title":"Addition of ATG to non-myeloablative peripheral blood haploidentical transplant with PTCY decreases acute GVHD rates and improves GVHD-relapse free survival","volume":"58","author":"Jullien","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2026.102438_bb0145","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1182\/bloodadvances.2022007611","article-title":"Chronic GvHD NIH consensus project biology task force: evolving path to personalized treatment of chronic GvHD","volume":"7","author":"Buxbaum","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2026.102438_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41408-022-00771-w","article-title":"Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial","volume":"13","author":"Zu","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.trim.2026.102438_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.921293","article-title":"Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia","volume":"13","author":"Barkhordar","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2026.102438_bb0160","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1080\/10428194.2021.1966781","article-title":"Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections","volume":"62","author":"Salas","year":"2021","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2026.102438_bb0165","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/bjh.70050","volume":"207","author":"Capes","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2026.102438_bb0170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/bloodadvances.2024014781","article-title":"PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation","volume":"9","author":"Desai","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2026.102438_bb0175","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1182\/blood.2025032569","article-title":"A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy","volume":"147","author":"Yang","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.trim.2026.102438_bb0180","article-title":"Randomized trial of anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide to prevent graft-versus-host disease in haploidentical transplantation","volume":"110","author":"Xu","year":"2025","journal-title":"Haematologica"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:53:45Z","timestamp":1788620025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S0966327426000961"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102438","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of low-dose antithymocyte globulin to post-transplant cyclophosphamide for effective graft-versus-host disease prophylaxis in peripheral blood stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102438"}}